Drug discovery in fish, flies, and worms

ILAR Journal

Volumn 57, Issue 2, 2016, Pages 133-143

  Strange, Kevin ^a  

^a Novo Biosciences   (United States)

Author keywords

Caenorhabditis elegans; Chemical biology; Danio rerio; Drosophila melanogaster; Drug screening; Phenotype based screening; Regenerative medicine; Target based screening

Indexed keywords

ANIMAL; CAENORHABDITIS ELEGANS; DISEASE MODEL; DROSOPHILA MELANOGASTER; DRUG DEVELOPMENT; HIGH THROUGHPUT SCREENING; HUMAN; PHYSIOLOGY;

ANIMALS; CAENORHABDITIS ELEGANS; DISEASE MODELS, ANIMAL; DROSOPHILA MELANOGASTER; DRUG DISCOVERY; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS;

EID: 85014495666     PISSN: 10842020     EISSN: 19306180     Source Type: Journal    
DOI: 10.1093/ilar/ilw034     Document Type: Article

References (112)

1. Abujarour R, Valamehr B. 2015. Generation of skeletal muscle cells from pluripotent stem cells: Advances and challenges. Front Cell Dev Biol 3:29.
2. Bellen HJ, Yamamoto S. 2015. Morgan's legacy: Fruit flies and the functional annotation of conserved genes. Cell 163: 12-14.
3. Birnbaum KD, Sanchez AA. 2008. Slicing across kingdoms: Regeneration in plants and animals. Cell 132:697-710.
4. Bitto A, Wang AM, Bennett CF, Kaeberlein M. 2015. Biochemical genetic pathways that modulate aging in multiple species. Cold Spring Harb Perspect Med 5:a025114.
5. Braungart E, Gerlach M, Riederer P, Baumeister R, Hoener MC. 2004. Caenorhabditis elegans MPP+ model of Parkinson's disease for high-throughput drug screenings. Neurodegener Dis 1:175-183.
6. Breger J, Fuchs BB, Aperis G, Moy TI, Ausubel FM, Mylonakis E. 2007. Antifungal chemical compounds identified using a C. elegans pathogenicity assay. PLoS Pathog 3:e18.
7. Brenner S. 1988. Foreward. In: Wood WB, the Community of C. elegans Researchers, eds. The Nematode Caenorhabditis elegans. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press. p ix-xiii.
8. Burns AR, Luciani GM, Musso G, Bagg R, Yeo M, Zhang Y, Rajendran L, Glavin J, Hunter R, Redman E, Stasiuk S, Schertzberg M, Angus MG, Caffrey CR, Cutler SR, Tyers M, Giaever G, Nislow C, Fraser AG, MacRae CA, Gilleard J, Roy PJ. 2015. Caenorhabditis elegans is a useful model for anthelmintic discovery. Nat Commun 6:7485.
9. Chang S, Bray SM, Li Z, Zarnescu DC, He C, Jin P, Warren ST. 2008. Identification of small molecules rescuing fragile X syndrome phenotypes in Drosophila. Nat Chem Biol 4:256-263.
10. Chen X, Barclay JW, Burgoyne RD, Morgan A. 2015. Using C. elegans to discover therapeutic compounds for ageingassociated neurodegenerative diseases. Chem Cent J 9: 65-0143.
11. Chen Y, Pu J, Zhang B. 2016. Progress and challenges of cell replacement therapy for neurodegenerative diseases based on direct neural reprogramming. Hum Gene Ther (in press).
12. Chi NC, Shaw RM, Jungblut B, Huisken J, Ferrer T, Arnaout R, Scott I, Beis D, Xiao T, Baier H, Jan LY, Tristani-Firouzi M, Stainier DY. 2008. Genetic and physiologic dissection of the vertebrate cardiac conduction system. PLoS Biol 6:e109.
13. Cohen LB, Troemel ER. 2015. Microbial pathogenesis and host defense in the nematode C. elegans. Curr Opin Microbiol 23: 94-101.
14. Cutler C, Multani P, Robbins D, Kim HT, Le T, Hoggatt J, Pelus LM, Desponts C, Chen YB, Rezner B, Armand P, Koreth J, Glotzbecker B, Ho VT, Alyea E, Isom M, Kao G, Armant M, Silberstein L, Hu P, Soiffer RJ, Scadden DT, Ritz J, Goessling W, North TE, Mendlein J, Ballen K, Zon LI, Antin JH, Shoemaker DD. 2013. Prostaglandin-modulated umbilical cord blood hematopoietic stem cell transplantation. Blood 122:3074-3081.
15. Dang M, Fogley R, Zon LI. 2016. Identifying novel cancer therapies using chemical genetics and zebrafish. Adv Exp Med Biol 916:103-124.
16. Das TK, Cagan RL. 2013. A Drosophila approach to thyroid cancer therapeutics. Drug Discov Today Technol 10:e65-e71.
17. DiLoreto R, Murphy CT. 2015. The cell biology of aging. Mol Biol Cell 26:4524-4531.
18. Fishman MC. 2001. Genomics. Zebrafish-the canonical vertebrate. Science 294:1290-1291.
19. Foglia MJ, Poss KD. 2016. Building and re-building the heart by cardiomyocyte proliferation. Development 143:729-740.
20. Fonseka TM, Wen XY, Foster JA, Kennedy SH. 2016. Zebrafish models of major depressive disorders. J Neurosci Res 94:3-14.
21. Frezal L, Felix MA. 2015. C. elegans outside the Petri dish. Elife 4.
22. Gallardo VE, Varshney GK, Lee M, Bupp S, Xu L, Shinn P, Crawford NP, Inglese J, Burgess SM. 2015. Phenotype-driven chemical screening in zebrafish for compounds that inhibit collective cell migration identifies multiple pathways potentially involved in metastatic invasion. Dis Model Mech 8: 565-576.
23. Gasque G, Conway S, Huang J, Rao Y, Vosshall LB. 2013. Small molecule drug screening in Drosophila identifies the 5HT2A receptor as a feeding modulation target. Sci Rep 3:srep02120.
24. Gemberling M, Bailey TJ, Hyde DR, Poss KD. 2013. The zebrafish as a model for complex tissue regeneration. Trends Genet 29:611-620.
25. Genge CE, Lin E, Lee L, Sheng X, Rayani K, Gunawan M, Stevens CM, Li AY, Talab SS, Claydon TW, Hove-Madsen L, Tibbits GF. 2016. The zebrafish heart as a model of mammalian cardiac function. Rev Physiol Biochem Pharmacol (in press).
26. Ghaemi R, Selvaganapathy PR. 2016. Microfluidic devices for automation of assays on Drosophila melanogaster for applications in drug discovery and biological studies. Curr Pharm Biotechnol 17:822-836.
27. Giacomotto J, Segalat L. 2010. High-throughput screening and small animal models, where are we? Br J Pharmacol 160: 204-216.
28. Gillespie ZE, Pickering J, Eskiw CH. 2016. Better living through chemistry: Caloric restriction (CR) and CR mimetics alter genome function to promote increased health and lifespan. Front Genet 7:142.
29. Goessling W, Allen RS, Guan X, Jin P, Uchida N, Dovey M, Harris JM, Metzger ME, Bonifacino AC, Stroncek D, Stegner J, Armant M, Schlaeger T, Tisdale JF, Zon LI, Donahue RE, North TE. 2011. Prostaglandin E2 enhances human cord blood stem cell xenotransplants and shows long-term safety in preclinical nonhuman primate transplant models. Cell Stem Cell 8:445-458.
30. Goessling W, North TE. 2014. Repairing quite swimmingly: Advances in regenerative medicine using zebrafish. Dis Model Mech 7:769-776.
31. Grunwald DJ, Eisen JS. 2002. Headwaters of the zebrafish-emergence of a new model vertebrate. Nat Rev Genet 3: 717-724.
32. Hofherr A, Wagner CJ, Watnick T, Kottgen M. 2016. Targeted rescue of a polycystic kidney disease mutation by lysosomal inhibition. Kidney Int 89:949-955.
33. Howe K, Clark MD, Torroja CF, Torrance J, Berthelot C, Muffato M, Collins JE, Humphray S, McLaren K, Matthews L, McLaren S, Sealy I, Caccamo M, Churcher C, Scott C, Barrett JC, Koch R, Rauch GJ, White S, Chow W, Kilian B, Quintais LT, Guerra-Assuncao JA, Zhou Y, Gu Y, Yen J, Vogel JH, Eyre T, Redmond S, Banerjee R, Chi J, Fu B, Langley E, Maguire SF, Laird GK, Lloyd D, Kenyon E, Donaldson S, Sehra H, Almeida-King J, Loveland J, Trevanion S, Jones M, Quail M, Willey D, Hunt A, Burton J, Sims S, McLay K, Plumb B, Davis J, Clee C, Oliver K, Clark R, Riddle C, Elliot D, Threadgold G, Harden G, Ware D, Begum S, Mortimore B, Kerry G, Heath P, Phillimore B, Tracey A, Corby N, Dunn M, Johnson C, Wood J, Clark S, Pelan S, Griffiths G, Smith M, Glithero R, Howden P, Barker N, Lloyd C, Stevens C, Harley J, Holt K, Panagiotidis G, Lovell J, Beasley H, Henderson C, Gordon D, Auger K, Wright D, Collins J, Raisen C, Dyer L, Leung K, Robertson L, Ambridge K, Leongamornlert D, McGuire S, Gilderthorp R, Griffiths C, Manthravadi D, Nichol S, Barker G, Whitehead S, Kay M, Brown J, Murnane C, Gray E, Humphries M, Sycamore N, Barker D, Saunders D, Wallis J, Babbage A, Hammond S, Mashreghi-Mohammadi M, Barr L, Martin S, Wray P, Ellington A, Matthews N, Ellwood M, Woodmansey R, Clark G, Cooper J, Tromans A, Grafham D, Skuce C, Pandian R, Andrews R, Harrison E, Kimberley A, Garnett J, Fosker N, Hall R, Garner P, Kelly D, Bird C, Palmer S, Gehring I, Berger A, Dooley CM, Ersan-Urun Z, Eser C, Geiger H, Geisler M, Karotki L, Kirn A, Konantz J, Konantz M, Oberlander M, Rudolph-Geiger S, Teucke M, Lanz C, Raddatz G, Osoegawa K, Zhu B, Rapp A, Widaa S, Langford C, Yang F, Schuster SC, Carter NP, Harrow J, Ning Z, Herrero J, Searle SM, Enright A, Geisler R, Plasterk RH, Lee C, Westerfield M, de Jong PJ, Zon LI, Postlethwait JH, Nusslein-Volhard C, Hubbard TJ, Roest CH, Rogers J, Stemple DL. 2013. The zebrafish reference genome sequence and its relationship to the human genome. Nature 496:498-503.
34. Hu Y, Platzer EG, Bellier A, Aroian RV. 2010. Discovery of a highly synergistic anthelmintic combination that shows mutual hypersusceptibility. Proc Natl Acad Sci USA 107: 5955-5960.
35. Ishaq O, Sadanandan SK, Wahlby C. 2016. Deep fish: Deep learning-based classification of zebrafish deformation for high-throughput screening. J Biomol Screen (in press).
36. Kin Pong U, Subramanian V, Nicholas AP, Thompson PR, Ferretti P. 2014. Modulation of calcium-induced cell death in human neural stem cells by the novel peptidylarginine deiminase-AIF pathway. Biochim Biophys Acta 1843: 1162-1171.
37. King BL, Yin VP. 2016. A conserved microRNA regulatory circuit is differentially controlled during limb/appendage regeneration. PLoS One 11:e0157106.
38. Kong C, Yehye WA, Abd RN, Tan MW, Nathan S. 2014. Discovery of potential anti-infectives against Staphylococcus aureus using a Caenorhabditis elegans infection model. BMC Complement Altern Med 14:4.
39. Labbadia J, Morimoto RI. 2014. Proteostasis and longevity: When does aging really begin? F1000 Prime Rep 6:7.
40. Lange S, Gogel S, Leung KY, Vernay B, Nicholas AP, Causey CP, Thompson PR, Greene ND, Ferretti P. 2011. Protein deiminases: New players in the developmentally regulated loss of neural regenerative ability. Dev Biol 355:205-214.
41. Längle D, Halver J, Rathmer B, Willems E, Schade D. 2014. Small molecules targeting in vivo tissue regeneration. ACS Chem Biol 9:57-71.
42. Lawrence C, Mason T. 2012. Zebrafish housing systems: a review of basic operating principles and considerations for design and functionality. ILAR J 53:179-191.
43. Lee JA, Berg EL. 2013. Neoclassic drug discovery: The case for lead generation using phenotypic and functional approaches. J Biomol Screen 18:1143-1155.
44. Lepesant JA. 2015. The promises of neurodegenerative disease modeling. C R Biol 338:584-592.
45. Levine BD, Cagan RL. 2016. Drosophila lung cancer models identify trametinib plus statin as candidate therapeutic. Cell Rep 14:1477-1487.
46. Lin CY, Chiang CY, Tsai HJ. 2016. Zebrafish and Medaka: New model organisms for modern biomedical research. J Biomed Sci 23:19.
47. Lisse TS, Middleton LJ, Pellegrini AD, Martin PB, Spaulding EL, Lopes O, Brochu EA, Carter EV, Waldron A, Rieger S. 2016. Paclitaxel-induced epithelial damage and ectopic MMP-13 expression promotes neurotoxicity in zebrafish. Proc Natl Acad Sci U S A 113:E2189-E2198.
48. Liu Y, Asnani A, Zou L, Bentley VL, Yu M, Wang Y, Dellaire G, Sarkar KS, Dai M, Chen HH, Sosnovik DE, Shin JT, Haber DA, Berman JN, Chao W, Peterson RT. 2014. Visnagin protects against doxorubicin-induced cardiomyopathy through modulation of mitochondrial malate dehydrogenase. Sci Transl Med 6:266ra170.
49. MacRae CA, Peterson RT. 2015. Zebrafish as tools for drug discovery. Nat Rev Drug Discov 14:721-731.
50. Maglioni S, Arsalan N, Ventura N. 2016. C. elegans screening strategies to identify pro-longevity interventions. Mech Ageing Dev 157:60-69.
51. Markstein M, Dettorre S, Cho J, Neumuller RA, Craig-Muller S, Perrimon N. 2014. Systematic screen of chemotherapeutics in Drosophila stem cell tumors. Proc Natl Acad Sci USA 111: 4530-4535.
52. Maves L. 2014. Recent advances using zebrafish animal models for muscle disease drug discovery. Expert Opin Drug Discov 9:1033-1045.
53. McCormick AV, Wheeler JM, Guthrie CR, Liachko NF, Kraemer BC. 2013. Dopamine D2 receptor antagonism suppresses tau aggregation and neurotoxicity. Biol Psychiatry 73:464-471.
54. Millburn GH, Crosby MA, Gramates LS, Tweedie S. 2016. FlyBase portals to human disease research using Drosophila models. Dis Model Mech 9:245-252.
55. Moy TI, Ball AR, Anklesaria Z, Casadei G, Lewis K, Ausubel FM. 2006. Identification of novel antimicrobials using a liveanimal infection model. Proc Natl Acad Sci USA 103: 10414-10419.
56. Moy TI, Conery AL, Larkins-Ford J, Wu G, Mazitschek R, Casadei G, Lewis K, Carpenter AE, Ausubel FM. 2009. Highthroughput screen for novel antimicrobials using a whole animal infection model. ACS Chem Biol 4:527-533.
57. Nall AH, Sehgal A. 2013. Small-molecule screen in adult Drosophila identifies VMAT as a regulator of sleep. J Neurosci 33:8534-8540.
58. Namdaran P, Reinhart KE, Owens KN, Raible DW, Rubel EW. 2012. Identification of modulators of hair cell regeneration in the zebrafish lateral line. J Neurosci 32:3516-3528.
59. Nicolson T. 2005. The genetics of hearing and balance in zebrafish. Annu Rev Genet 39:9-22:9-22.
60. North TE, Goessling W, Walkley CR, Lengerke C, Kopani KR, Lord AM, Weber GJ, Bowman TV, Jang IH, Grosser T, Fitzgerald GA, Daley GQ, Orkin SH, Zon LI. 2007. Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis. Nature 447:1007-1011.
61. O'Meara CC, Wamstad JA, Gladstone RA, Fomovsky GM, Butty VL, Shrikumar A, Gannon JB, Boyer LA, Lee RT. 2015. Transcriptional reversion of cardiac myocyte fate during mammalian cardiac regeneration. Circ Res 116:804-815.
62. O'Reilly LP, Luke CJ, Perlmutter DH, Silverman GA, Pak SC. 2014. C. elegans in high-throughput drug discovery. Adv Drug Deliv Rev 69-70:247-253.
63. Owens KN, Santos F, Roberts B, Linbo T, Coffin AB, Knisely AJ, Simon JA, Rubel EW, Raible DW. 2008. Identification of genetic and chemical modulators of zebrafish mechanosensory hair cell death. PLoS Genet 4:e1000020.
64. Park CY, Tseng D, Weissman IL. 2009. Cancer stem cell-directed therapies: Recent data from the laboratory and clinic. Mol Ther 17:219-230.
65. Peddibhotla S, Leung CK, Maloney P, Hershberger PM, Nguyen K, Vasile S, Suyama E, Kane A, Bousquet MS, Leusch H, Stonich D, Mangravita-Novo A, Salaniwal S, Kung P, Diwan J, Smith LH, Chung TDY, Pinkerton AB, Malany S, Choe K. 2014. A high throughput screen for inhibitors of nematode detoxification genes. Probe Reports from the NIH Molecular Libraries Program [Internet]. Bethesda (MD): National Center for Biotechnology Information (US)
66. Petrascheck M, Ye X, Buck LB. 2007. An antidepressant that extends lifespan in adult Caenorhabditis elegans. Nature 450: 553-556.
67. Porrello ER, Mahmoud AI, Simpson E, Hill JA, Richardson JA, Olson EN, Sadek HA. 2011. Transient regenerative potential of the neonatal mouse heart. Science 331:1078-1080.
68. Porrello ER, Olson EN. 2014. A neonatal blueprint for cardiac regeneration. Stem Cell Res 13:556-570.
69. Powell JR, Ausubel FM. 2008. Models of Caenorhabditis elegans infection by bacterial and fungal pathogens. Methods Mol Biol 415:403-427.
70. Pukkila-Worley R, Feinbaum R, Kirienko NV, Larkins-Ford J, Conery AL, Ausubel FM. 2012. Stimulation of host immune defenses by a small molecule protects C. elegans from bacterial infection. PLoS Genet 8:e1002733.
71. Reiter LT, Potocki L, Chien S, Gribskov M, Bier E. 2001. A systematic analysis of human disease-associated gene sequences in Drosophila melanogaster. Genome Res 11:1114-1125.
72. Robertson AL, Holmes GR, Bojarczuk AN, Burgon J, Loynes CA, Chimen M, Sawtell AK, Hamza B, Willson J, Walmsley SR, Anderson SR, Coles MC, Farrow SN, Solari R, Jones S, Prince LR, Irimia D, Rainger GE, Kadirkamanathan V, Whyte MK, Renshaw SA. 2014. A zebrafish compound screen reveals modulation of neutrophil reverse migration as an antiinflammatory mechanism. Sci Transl Med 6:225ra29.
73. Rozehal, J. M., Posner, M. R., Ang, C, Bangi, E., Yeykal, C., Cagan, R. L., Dang, R. P., Donovan, M., Uzilov, A. V., Antipin, Y., Schadl, E. E., and Misiukiewicz, K. 2016. Transgenic Drosophila as a drug-screening platform for colorectal cancer and medullary thyroid cancer. J Clin Oncol 34: abstract e23164.
74. Rubin GM, Yandell MD, Wortman JR, Gabor Miklos GL, Nelson CR, Hariharan IK, Fortini ME, Li PW, Apweiler R, Fleischmann W, Cherry JM, Henikoff S, Skupski MP, Misra S, Ashburner M, Birney E, Boguski MS, Brody T, Brokstein P, Celniker SE, Chervitz SA, Coates D, Cravchik A, Gabrielian A, Galle RF, Gelbart WM, George RA, Goldstein LS, Gong F, Guan P, Harris NL, Hay BA, Hoskins RA, Li J, Li Z, Hynes RO, Jones SJ, Kuehl PM, Lemaitre B, Littleton JT, Morrison DK, Mungall C, O'Farrell PH, Pickeral OK, Shue C, Vosshall LB, Zhang J, Zhao Q, Zheng XH, Lewis S. 2000. Comparative genomics of the eukaryotes. Science 287:2204-2215.
75. Sanders GE. 2012. Zebrafish housing, husbandry, health, and care: IACUC considerations. ILAR J 53:205-207.
76. Scudellari M. 2015. My mighty mouse. The Scientist 29.
77. Sedo-Cabezon L, Boadas-Vaello P, Soler-Martin C, Llorens J. 2014. Vestibular damage in chronic ototoxicity: A minireview. Neurotoxicology 43:21-27.
78. Seguin A, Monnier V, Palandri A, Bihel F, Rera M, Schmitt M, Camadro JM, Tricoire H, Lesuisse E. 2015. A yeast/Drosophila screen to identify new compounds overcoming frataxin deficiency. Oxid Med Cell Longev 2015:565140.
79. Selin C, Stietz MS, Blanchard JE, Gehrke SS, Bernard S, Hall DG, Brown ED, Cardona ST. 2015. A pipeline for screening small molecules with growth inhibitory activity against Burkholderia cenocepacia. PLoS One 10:e0128587.
80. Shaye DD, Greenwald I. 2011. OrthoList: a compendium of C. elegans genes with human orthologs. PLoS One 6:e20085.
81. Shim YH, Paik YK. 2010. Caenorhabditis elegans proteomics comes of age. Proteomics 10:846-857.
82. Simpson KJ, Davis GM, Boag PR. 2012. Comparative highthroughput RNAi screening methodologies in C. elegans and mammalian cells. N Biotechnol 29:459-470.
83. Sleigh JN, Buckingham SD, Esmaeili B, Viswanathan M, Cuppen E, Westlund BM, Sattelle DB. 2011. A novel Caenorhabditis elegans allele, smn-1(cb131), mimicking a mild form of spinal muscular atrophy, provides a convenient drug screening platform highlighting new and pre-approved compounds. Hum Mol Genet 20:245-260.
84. Stewart AM, Braubach O, Spitsbergen J, Gerlai R, Kalueff AV. 2014. Zebrafish models for translational neuroscience research: From tank to bedside. Trends Neurosci 37:264-278.
85. Stilwell GE, Saraswati S, Littleton JT, Chouinard SW. 2006. Development of a Drosophila seizure model for in vivo highthroughput drug screening. Eur J Neurosci 24:2211-2222.
86. Strange K. 2003. From genes to integrative physiology: Ion channel and transporter biology in Caenorhabditis elegans. Physiol Rev 83:377-415.
87. Streit AK, Fan YN, Masullo L, Baines RA. 2016. Calcium imaging of neuronal activity in Drosophila can identify anticonvulsive compounds. PLoS One 11:e0148461.
88. Sturtevant AH. 1959. Thomas Hunt Morgan. Biographical Memoirs National Academy of Sciences 33:283-325.
89. Swinney DC, Anthony J. 2011. How were new medicines discovered? Nat Rev Drug Discov 10:507-519.
90. Tanaka EM. 2016. The molecular and cellular choreography of appendage regeneration. Cell 165:1598-1608.
91. Tanaka EM, Reddien PW. 2011. The cellular basis for animal regeneration. Dev Cell 21:172-185.
92. Tat J, Liu M, Wen XY. 2013. Zebrafish cancer and metastasis models for in vivo drug discovery. Drug Discov Today Technol 10:e83-e89.
93. Tsuji N, Ninov N, Delawary M, Osman S, Roh AS, Gut P, Stainier DY. 2014. Whole organism high content screening identifies stimulators of pancreatic b-cell proliferation. PLoS One 9: e104112.
94. Ugur B, Chen K, Bellen HJ. 2016. Drosophila tools and assays for the study of human diseases. Dis Model Mech 9:235-244.
95. U.S. Department of Health and Human Services. 2020: A new vision-a future for regenerative medicine. 2003. Available online (https://medicine.osu.edu/regenerativemedicine/documents/2020vision.pdf), accessed on November 2, 2016.
96. van der Ent W, Veneman WJ, Groenewoud A, Chen L, Tulotta C, Hogendoorn PC, Spaink HP, Snaar-Jagalska BE. 2016. Automation of technology for cancer research. Adv Exp Med Biol 916:315-332.
97. Veinotte CJ, Dellaire G, Berman JN. 2014. Hooking the big one: The potential of zebrafish xenotransplantation to reform cancer drug screening in the genomic era. Dis Model Mech 7:745-754.
98. Wagner BK, Schreiber SL. 2016. The power of sophisticated phenotypic screening and modern mechanism-of-action methods. Cell Chem Biol 23:3-9.
99. Wang G, Rajpurohit SK, Delaspre F, Walker SL, White DT, Ceasrine A, Kuruvilla R, Li RJ, Shim JS, Liu JO, Parsons MJ, Mumm JS. 2015. First quantitative high-throughput screen in zebrafish identifies novel pathways for increasing pancreatic b-cell mass. Elife 4.
100. Wang L, Hagemann TL, Messing A, Feany MB. 2016. An in vivo pharmacological screen identifies cholinergic signaling as a therapeutic target in glial-based nervous system disease. J Neurosci 36:1445-1455.
101. Wangler MF, Yamamoto S, Bellen HJ. 2015. Fruit flies in biomedical research. Genetics 199:639-653.
102. White R, Rose K, Zon L. 2013. Zebrafish cancer: The state of the art and the path forward. Nat Rev Cancer 13:624-636.
103. White RM, Cech J, Ratanasirintrawoot S, Lin CY, Rahl PB, Burke CJ, Langdon E, Tomlinson ML, Mosher J, Kaufman C, Chen F, Long HK, Kramer M, Datta S, Neuberg D, Granter S, Young RA, Morrison S, Wheeler GN, Zon LI. 2011. DHODH modulates transcriptional elongation in the neural crest and melanoma. Nature 471:518-522.
104. Wilkinson RN, Jopling C, van Eeden FJ. 2014. Zebrafish as a model of cardiac disease. Prog Mol Biol Transl Sci 124:65-91.
105. Willerson JT. 2015. Stem cell therapy for cardiovascular diseases: a progressive journey. Curr Opin Cardiol 30:205-212.
106. Williams CH, Hempel JE, Hao J, Frist AY, Williams MM, Fleming JT, Sulikowski GA, Cooper MK, Chiang C, Hong CC. 2015. An in vivo chemical genetic screen identifies phosphodiesterase 4 as a pharmacological target for hedgehog signaling inhibition. Cell Rep 11:43-50.
107. Williams CH, Hong CC. 2011. Multi-step usage of in vivo models during rational drug design and discovery. Int J Mol Sci 12: 2262-2274.
108. Wohlleben W, Mast Y, Stegmann E, Ziemert N. 2016. Antibiotic drug discovery. Microb Biotechnol 9:541-548.
109. Yadav AK, Srikrishna S, Gupta SC. 2016. Cancer drug development using Drosophila as an in vivo tool: From bedside to bench and back. Trends Pharmacol Sci 37:789-806.
110. Yang F, Gao C, Wang P, Zhang GJ, Chen Z. 2016. Fish-on-a-chip: Microfluidics for zebrafish research. Lab Chip 16:1106-1125.
111. Yauch RL, Dijkgraaf GJ, Alicke B, Januario T, Ahn CP, Holcomb T, Pujara K, Stinson J, Callahan CA, Tang T, Bazan JF, Kan Z, Seshagiri S, Hann CL, Gould SE, Low JA, Rudin CM, de Sauvage FJ. 2009. Smoothened mutation confers resistance to a Hedgehog pathway inhibitor in medulloblastoma. Science 326:572-574.
112. Zhang B, Xuan C, Ji Y, Zhang W, Wang D. 2015. Zebrafish xenotransplantation as a tool for in vivo cancer study. Fam Cancer 14:487-493.